Effective control of sickle cell disease with hydroxyurea therapy
2011
Comment on Hydroxyurea Therapy for Sickle Cell Disease
Commentary
Author Information
Author(s): Beedimani Ravindra S.
Primary Institution: American University of Caribbean, School of Medicine, St. Maarten, Netherlands Antilles
Conclusion
The author argues that the study on hydroxyurea therapy lacks novelty and questions its publication criteria.
Supporting Evidence
- The author has taught about hydroxyurea's effectiveness for 15 years.
- The topic has been well-studied and established in pharmacology.
Takeaway
The author thinks the study on hydroxyurea for sickle cell disease isn't new and questions why it was published.
Limitations
The author believes the study does not meet the novelty criteria for publication.
Want to read the original?
Access the complete publication on the publisher's website